e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.68
-0.37 (-1.42%)
Official Closing Price
Updated: 7:00 PM EDT, May 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
3 Healthcare Stocks Every Retiree Should Consider
↗
May 08, 2026
If you are trying to generate income in retirement, these three high-yield healthcare stocks could be the perfect fit for you.
Via
The Motley Fool
Topics
Intellectual Property
Retirement
Got $5,000 to Invest in a Volatile Market? Here's Exactly Where I'd Put It.
↗
May 08, 2026
Look for names that tend to trade independently of the overall market, and don't be afraid to achieve some income growth.
Via
The Motley Fool
Topics
Economy
What Are Horizontal Mergers and Acquisitions?
May 08, 2026
Via
BusinesNews Wire
Topics
Economy
GoodRx (GDRX) Q1 2026 Earnings Call Transcript
↗
May 08, 2026
GoodRx (GDRX) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Pfizer Inc. (NYSE:PFE) Tops Q1 2026 Estimates Amid Strong Non-COVID Growth
↗
May 05, 2026
Via
Chartmill
Will Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There.
↗
May 08, 2026
The competition is far behind.
Via
The Motley Fool
Forget Eli Lilly: These 2 Stocks Have More Upside
↗
May 07, 2026
Eli Lilly has a lofty valuation thanks to its strong GLP-1 growth, but don't count out these two competitors.
Via
The Motley Fool
What's going on in today's session: S&P500 most active stocks
↗
May 07, 2026
Via
Chartmill
Zoetis (NYSE:ZTS) Misses Q1 CY2026 Revenue Estimates, Stock Drops 13%
May 07, 2026
Animal health company Zoetis (NYSE:ZTS) missed Wall Street’s revenue expectations in Q1 CY2026 as sales only rose 1.9% year on year to $2.26 billion. The com...
Via
StockStory
Viatris’s (NASDAQ:VTRS) Q1 CY2026: Beats On Revenue
May 07, 2026
Medication company Viatris (NASDAQ:VTRS) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 8.1% year on year to $3.52 bil...
Via
StockStory
Topics
Artificial Intelligence
Pfizer's 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the Skeptics
↗
May 07, 2026
Is Pfizer a yield trap? No way.
Via
The Motley Fool
Topics
Artificial Intelligence
Earnings
Intellectual Property
History Suggests These 3 Stocks Are Due for a Major Rebound
↗
May 06, 2026
Investors often move like lemmings in the short term, giving long-term investors an opportunity to buy great companies.
Via
The Motley Fool
Topics
Economy
Intellectual Property
Novavax (NVAX) Q1 2026 Earnings Transcript
↗
May 06, 2026
Novavax (NVAX) Q1 2026 Earnings Transcript
Via
The Motley Fool
Novavax (NASDAQ:NVAX) Surprises With Strong Q1 CY2026, Stock Soars
May 06, 2026
Vaccine biotechnology company Novavax (NASDAQ:NVAX) beat Wall Street’s revenue expectations in Q1 CY2026, but sales fell by 79.1% year on year to $139.5 mill...
Via
StockStory
PFE Q1 Deep Dive: Oncology, Obesity Pipeline, and Legal Milestones Shape Outlook
May 06, 2026
Global pharmaceutical company Pfizer (NYSE:PFE) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 5.4% year on year to $14.45 ...
Via
StockStory
Topics
Intellectual Property
Down as Much as 55% and Still Magnificent: 3 Dividend Stocks Worth Holding for a Lifetime
↗
May 05, 2026
Just because a dividend stock has suffered a significant stumble doesn't mean the setback is permanent. It doesn't even mean its dividend is in jeopardy.
Via
The Motley Fool
Pfizer (PFE) Q1 2026 Earnings Transcript
↗
May 05, 2026
Pfizer (PFE) Q1 2026 Earnings Transcript
Via
The Motley Fool
Topics
Intellectual Property
Explore the S&P500 index on Tuesday and find out which stocks are the most active in today's session.
↗
May 05, 2026
Via
Chartmill
Pfizer Says Vyndamax Drug Patent Settlement Reshapes Post-2028 Revenue View
↗
May 05, 2026
Pfizer beats Q1 estimates with revenue growth and strong pipeline progress, extends Vyndamax patent outlook, and backs 2026 guidance.
Via
Benzinga
Topics
Intellectual Property
Dow Jumps Over 300 Points; Tyson Foods Posts Upbeat Earnings
↗
May 05, 2026
US stocks rise, Dow gains 300 points. Materials jump 1.8%, real estate falls 0.2%. Pfizer's Q1 earnings beat expectations. Asian markets close lower.
Via
Benzinga
Topics
Earnings
Stocks
Why Pfizer's 'Mild' First-Quarter Report Likely Won't Satisfy Skeptics
↗
May 05, 2026
Pfizer delivered better-than-expected sales and profit.
Via
Investor's Business Daily
Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q1 CY2026
May 05, 2026
Global pharmaceutical company Pfizer (NYSE:PFE) announced better-than-expected revenue in Q1 CY2026, with sales up 5.4% year on year to $14.45 billion. On th...
Via
StockStory
Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance
May 05, 2026
From
Pfizer Inc.
Via
Business Wire
Poets&Quants™ Names Best & Brightest MBAs of 2026
May 05, 2026
May 5, 2026 -- Annual feature celebrates graduating business students for campus impact and professional achievement
Via
24-7 Press Release
Pfizer, Pinterest And 3 Stocks To Watch Heading Into Tuesday
↗
May 05, 2026
US stock futures up, key stocks to watch today: Pfizer, Pinterest, PayPal, ON Semiconductor, AMD. Check out Benzinga Pro's premarket coverage.
Via
Benzinga
Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind Breast Cancer Therapy
↗
May 04, 2026
Pfizer and Arvinas secure FDA approval for VEPPANU (vepdegestrant), a first-of-its-kind treatment for ESR1-mutated advanced breast cancer.
Via
Benzinga
Eli Lilly Topples After Weight-Loss Patient Reports A Surprise Side Effect
↗
May 04, 2026
Eli Lilly stock toppled Monday after a patient taking its new weight-loss pill, Foundayo, experienced liver failure.
Via
Investor's Business Daily
How To Earn $500 A Month From Pfizer Stock Ahead Of Q1 Earnings
↗
May 04, 2026
Pfizer to release Q3 earnings on May 5, with analysts expecting 72 cents/share and a revenue of $13.8 billion. Annual dividend yield at 6.53%.
Via
Benzinga
Eli Lilly Just Announced Fantastic News for Shareholders
↗
May 04, 2026
Lilly's weight loss drugs have been delivering blockbuster revenue.
Via
The Motley Fool
Topics
Earnings
Pfizer Earnings: What To Look For From PFE
May 03, 2026
Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting results this Tuesday before the bell. Here’s what investors should know. Pfizer beat analys...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.